Nanotechnology is poised to revolutionize the diagnosis and treatment of patients with type 1 diabetes.
Nanomedicine offers hope in battling endometriosis
Endometriosis is a chronic, painful condition that affects millions of women worldwide. Now, a new nanoplatform offers hope for early diagnosis and effective ablation of endometriosis.
An antidiabetic drug in the fight against antibiotic resistance
A research team combats antibiotic-resistant superbugs by administering antibiotics together with metformin.
A new deep-learning architecture for drug discovery
Convolutional neural networks provide stronger predictive performances for pharmacological assays compared to traditional machine learning models.
Tracking and analysis of SARS-CoV-2 spike protein mutations
Understanding changes to the spike protein’s structure is critical to the development of an effective vaccine.
Screw cancer: Microneedle sticks it to cancer tissue
Scientists are finding safer ways to keep drug-loaded microrobots attached to cancer tissue.
Predicting the behavior of macromolecules
Researchers at Houston Methodist Research Institute discuss how quantitative, non-invasive imaging can aid in developing novel tools for diagnosis and therapy.
Does the dusk of “old-school antibiotics” mean the dawn of antimicrobial nanomaterials?
Antibiotic-resistant bacteria are becoming a major global threat. Novel antibacterial nanomaterials offer a solution.
Killing cancer with iron
Researchers at the University of Munich have demonstrated a conceptually novel nanocarrier strategy in which the nanoparticles are both the cargo and the carrier.
Recruiting AI in the battle against SARS-CoV-2 and future pandemics
A new AI system can identify optimal combinations of drugs and dosages in a matter of days to help halt viral pandemics before they reach global scales.